// App-Quantinova.ai

AB0021 (2021) : CHARACTERISATION OF AGE-ASSOCIATED B CELLS IN EARLY, DRUG NAÏVE RHEUMATOID ARTHRITIS

Researchers

Presenter

  • G. Vidal-Pedrola

Principal Investigators

  • N. Naamane

  • D. Scheel-Toellner

  • A. Pratt

  • A. Mellor

  • J. D. Isaacs

  • A. E. Anderson

Medical Centers

  • Newcastle University, Translational and Clinical Research Institute, Newcastle Upon Tyne, United Kingdom

  • University of Birmingham, Centre for Translational Inflammation Research, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

  • Rheumatoid arthritis

Biomarkers

  • Cluster of Differentiation 11c

  • Complement component receptor 2

  • Cluster of Differentiation 19

Drug/Treatment

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A